GCSAML
gene geneOn this page
Also known as FLJ44728
Summary
GCSAML (germinal center associated signaling and motility like, HGNC:29583) is a protein-coding gene on chromosome 1q44, encoding Germinal center-associated signaling and motility-like protein (Q5JQS6).
This gene encodes a protein thought to be a signaling molecule associated with germinal centers, the sites of proliferation and differentiation of mature B lymphocytes. Alternate splicing results in multiple transcript variants.
Source: NCBI Gene 148823 — RefSeq curated summary.
At a glance
- GWAS associations: 25
- Clinical variants (ClinVar): 71 total — 1 pathogenic
- MANE Select transcript:
NM_145278
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29583 |
| Approved symbol | GCSAML |
| Name | germinal center associated signaling and motility like |
| Location | 1q44 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ44728 |
| Ensembl gene | ENSG00000169224 |
| Ensembl biotype | protein_coding |
| Entrez | 148823 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 10 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000366488, ENST00000366489, ENST00000366491, ENST00000463359, ENST00000526896, ENST00000527084, ENST00000527541, ENST00000529512, ENST00000531662, ENST00000536561, ENST00000623578
RefSeq mRNA: 7 — MANE Select: NM_145278
NM_001281834, NM_001281835, NM_001281836, NM_001281837, NM_001281838, NM_001281853, NM_145278
CCDS: CCDS1635, CCDS60470, CCDS73058
Canonical transcript exons
ENST00000366488 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001441828 | 247574143 | 247577690 |
| ENSE00001742146 | 247565931 | 247565959 |
| ENSE00002186018 | 247549134 | 247549220 |
| ENSE00003502756 | 247556407 | 247556466 |
| ENSE00003681324 | 247563590 | 247563639 |
Expression profiles
Bgee: expression breadth ubiquitous, 149 present calls, max score 92.46.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 15.9501 / max 14238.0199, expressed in 139 samples.
FANTOM5 promoters (11 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 9621 | 12.9400 | 121 |
| 9620 | 2.3057 | 48 |
| 9622 | 0.3533 | 27 |
| 9619 | 0.1710 | 34 |
| 9618 | 0.0885 | 11 |
| 9616 | 0.0251 | 13 |
| 202043 | 0.0238 | 8 |
| 9617 | 0.0163 | 6 |
| 202044 | 0.0148 | 5 |
| 9613 | 0.0079 | 3 |
Top tissues by expression
239 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 92.46 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 81.79 | gold quality |
| monocyte | CL:0000576 | 74.96 | gold quality |
| leukocyte | CL:0000738 | 74.03 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 70.27 | gold quality |
| right testis | UBERON:0004534 | 69.57 | gold quality |
| left testis | UBERON:0004533 | 69.27 | gold quality |
| testis | UBERON:0000473 | 68.64 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 68.21 | gold quality |
| cerebellar cortex | UBERON:0002129 | 68.13 | gold quality |
| cerebellum | UBERON:0002037 | 67.62 | gold quality |
| bone marrow cell | CL:0002092 | 65.94 | silver quality |
| prostate gland | UBERON:0002367 | 65.24 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 64.29 | gold quality |
| gall bladder | UBERON:0002110 | 64.16 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 62.66 | gold quality |
| rectum | UBERON:0001052 | 62.26 | gold quality |
| colonic epithelium | UBERON:0000397 | 61.49 | gold quality |
| vermiform appendix | UBERON:0001154 | 59.69 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 57.91 | gold quality |
| lower esophagus | UBERON:0013473 | 57.86 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 57.52 | gold quality |
| blood | UBERON:0000178 | 56.72 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 56.39 | gold quality |
| right lung | UBERON:0002167 | 55.89 | gold quality |
| upper lobe of lung | UBERON:0008948 | 55.89 | gold quality |
| cerebellar vermis | UBERON:0004720 | 55.74 | gold quality |
| caecum | UBERON:0001153 | 55.41 | gold quality |
| cortical plate | UBERON:0005343 | 54.67 | silver quality |
| right coronary artery | UBERON:0001625 | 54.12 | gold quality |
Single-cell (SCXA)
Detected in 8 experiment(s), a significant marker in 7.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-29 | yes | 3173.49 |
| E-MTAB-6678 | yes | 697.48 |
| E-ANND-3 | yes | 16.01 |
| E-MTAB-9067 | yes | 11.53 |
| E-GEOD-130148 | yes | 7.47 |
| E-HCAD-10 | yes | 7.01 |
| E-MTAB-9801 | yes | 6.33 |
| E-CURD-112 | no | 2.95 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
118 targeting GCSAML, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6798-5P | 100.00 | 65.77 | 699 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
Literature-anchored findings (GeneRIF, showing 1)
- Maternal 5mCpG imprints at the GCSAML somatic (secondary) differentially methylated region (iDMR) are decoupled from parent-of-origin expression effects in multiple human tissues. Despite the constitutive methylation asymmetry observed for the parental alleles at the iDMR, GCSAML was expressed biallelically in five tissues: visceral adipose tissue, brain - cerebellar hemisphere, brain cerebellum, prostate, and testis. (PMID:29545821)
Cross-species orthologs
0 orthologs
Paralogs (1): GCSAM (ENSG00000174500)
Protein
Protein identifiers
Germinal center-associated signaling and motility-like protein — Q5JQS6 (reviewed: Q5JQS6)
All UniProt accessions (4): Q5JQS6, E9PLW0, E9PR51, E9PRX8
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5JQS6-1 | 1 | yes |
| Q5JQS6-2 | 2 |
RefSeq proteins (7): NP_001268763, NP_001268764, NP_001268765, NP_001268766, NP_001268767, NP_001268782, NP_660321* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031364 | GC_assoc_lym | Family |
Pfam: PF15666
UniProt features (6 total): compositionally biased region 2, chain 1, region of interest 1, coiled-coil region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5JQS6-F1 | 66.66 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 69 (showing top):
GOBP_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY, GOBP_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY, GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY, GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION, GOBP_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION, GOBP_LEUKOCYTE_MIGRATION, GOBP_REGULATION_OF_IMMUNE_RESPONSE, GOBP_LYMPHOCYTE_MIGRATION, chr1q44, GOBP_B_CELL_RECEPTOR_SIGNALING_PATHWAY, GOBP_REGULATION_OF_LYMPHOCYTE_MIGRATION, GOBP_ACTIVATION_OF_IMMUNE_RESPONSE, WIERENGA_STAT5A_TARGETS_DN, GOBP_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY, GOBP_MONONUCLEAR_CELL_MIGRATION
GO Biological Process (2): regulation of B cell receptor signaling pathway (GO:0050855), regulation of lymphocyte migration (GO:2000401)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| B cell receptor signaling pathway | 1 |
| regulation of antigen receptor-mediated signaling pathway | 1 |
| regulation of mononuclear cell migration | 1 |
| lymphocyte migration | 1 |
| binding | 1 |
Protein interactions and networks
STRING
334 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GCSAML | SEZ6L | Q9BYH1 | 531 |
| GCSAML | SAMD12 | Q8N8I0 | 489 |
| GCSAML | CALHM3 | Q86XJ0 | 477 |
| GCSAML | MTMR8 | Q96EF0 | 438 |
| GCSAML | OR2C3 | Q8N628 | 432 |
| GCSAML | ZNF71 | Q9NQZ8 | 429 |
| GCSAML | E9PNW1 | E9PNW1 | 419 |
| GCSAML | PTPRE | P23469 | 417 |
| GCSAML | DHRS13 | Q6UX07 | 413 |
| GCSAML | CSTPP1 | Q9H6J7 | 400 |
| GCSAML | CLVS1 | Q8IUQ0 | 396 |
| GCSAML | CCDC71L | Q8N9Z2 | 396 |
| GCSAML | TMTC2 | Q8N394 | 375 |
| GCSAML | KLHDC8B | Q8IXV7 | 373 |
| GCSAML | GAL3ST4 | Q96RP7 | 370 |
| GCSAML | LONRF3 | Q496Y0 | 370 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PRKAB2 | GCSAML | psi-mi:“MI:0915”(physical association) | 0.560 |
| STAMBPL1 | GCSAML | psi-mi:“MI:0915”(physical association) | 0.560 |
| GCSAML | NTAQ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GCSAML | EAF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GCSAML | STAMBPL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GCSAML | UBL5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GCSAML | EIF1AD | psi-mi:“MI:0915”(physical association) | 0.560 |
| GCSAML | FAM90A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GCSAML | SPAG9 | psi-mi:“MI:0914”(association) | 0.350 |
| NTAQ1 | GCSAML | psi-mi:“MI:0915”(physical association) | 0.000 |
| EAF1 | GCSAML | psi-mi:“MI:0915”(physical association) | 0.000 |
| UBL5 | GCSAML | psi-mi:“MI:0915”(physical association) | 0.000 |
| EIF1AD | GCSAML | psi-mi:“MI:0915”(physical association) | 0.000 |
| FAM90A1 | GCSAML | psi-mi:“MI:0915”(physical association) | 0.000 |
| GCSAML | EIF1AD | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (12): GCSAML (Two-hybrid), GCSAML (Two-hybrid), GCSAML (Two-hybrid), GCSAML (Two-hybrid), FAM90A1 (Two-hybrid), EIF1AD (Two-hybrid), UBL5 (Two-hybrid), SASS6 (Affinity Capture-MS), PLXDC2 (Affinity Capture-MS), MARS2 (Affinity Capture-MS), SPAG9 (Affinity Capture-MS), ZMYM6 (Affinity Capture-MS)
ESM2 similar proteins: A0JNM1, D3Z1Q2, P16871, P20963, P24161, P29329, P59773, Q16655, Q29102, Q2KIP5, Q2YDG7, Q3SYX1, Q3U1F9, Q3UU41, Q3UU67, Q4W815, Q5DTU0, Q5E9I3, Q5JQS6, Q6ITQ4, Q6PF55, Q6PIZ9, Q6RFH4, Q6UWF3, Q6XQ84, Q6ZUJ8, Q6ZWK4, Q80VH0, Q80WK2, Q86UW2, Q8C115, Q8C4Q9, Q8CB93, Q8N292, Q8N4X5, Q8N6F7, Q8NDB2, Q8NEA5, Q90479, Q90VY2
Diamond homologs: Q5JQS6, Q6RFH4, Q8N6F7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
71 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 63 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 253547 | GRCh37/hg19 1q43-44(chr1:243103401-249119318)x1 | Pathogenic |
SpliceAI
1595 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:247507229:GCTGG:G | donor_gain | 1.0000 |
| 1:247507232:GG:G | donor_gain | 1.0000 |
| 1:247507233:GG:G | donor_gain | 1.0000 |
| 1:247556392:T:G | acceptor_gain | 1.0000 |
| 1:247556392:T:TA | acceptor_gain | 1.0000 |
| 1:247556402:T:G | acceptor_gain | 1.0000 |
| 1:247556405:A:AG | acceptor_gain | 1.0000 |
| 1:247556406:G:GA | acceptor_gain | 1.0000 |
| 1:247556406:GTT:G | acceptor_gain | 1.0000 |
| 1:247556463:AACGG:A | donor_loss | 1.0000 |
| 1:247556464:ACGG:A | donor_loss | 1.0000 |
| 1:247556465:CGGT:C | donor_loss | 1.0000 |
| 1:247556466:GGTA:G | donor_loss | 1.0000 |
| 1:247556467:G:GG | donor_gain | 1.0000 |
| 1:247556468:T:TC | donor_loss | 1.0000 |
| 1:247563586:GTA:G | acceptor_loss | 1.0000 |
| 1:247563588:A:AG | acceptor_gain | 1.0000 |
| 1:247563589:G:GA | acceptor_loss | 1.0000 |
| 1:247563589:G:GG | acceptor_gain | 1.0000 |
| 1:247563589:GGCA:G | acceptor_gain | 1.0000 |
| 1:247563635:GAAAA:G | donor_gain | 1.0000 |
| 1:247563636:AAAA:A | donor_gain | 1.0000 |
| 1:247563637:AAA:A | donor_gain | 1.0000 |
| 1:247563638:AA:A | donor_gain | 1.0000 |
| 1:247563639:AGTAA:A | donor_loss | 1.0000 |
| 1:247563640:G:GG | donor_gain | 1.0000 |
| 1:247563641:T:G | donor_loss | 1.0000 |
| 1:247565921:A:AG | acceptor_gain | 1.0000 |
| 1:247507230:CTGG:C | donor_gain | 0.9900 |
| 1:247507230:CTGGG:C | donor_loss | 0.9900 |
AlphaMissense
897 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:247574302:T:C | Y110H | 0.975 |
| 1:247574303:A:C | Y110S | 0.967 |
| 1:247574179:T:G | Y69D | 0.956 |
| 1:247574247:C:A | N91K | 0.954 |
| 1:247574247:C:G | N91K | 0.954 |
| 1:247574302:T:G | Y110D | 0.951 |
| 1:247574305:G:C | A111P | 0.948 |
| 1:247574303:A:G | Y110C | 0.946 |
| 1:247549195:G:A | G2R | 0.922 |
| 1:247549195:G:C | G2R | 0.922 |
| 1:247574302:T:A | Y110N | 0.915 |
| 1:247574243:A:T | E90V | 0.914 |
| 1:247574179:T:A | Y69N | 0.912 |
| 1:247574309:T:C | L112P | 0.909 |
| 1:247574239:T:C | Y89H | 0.907 |
| 1:247574240:A:C | Y89S | 0.902 |
| 1:247574239:T:G | Y89D | 0.901 |
| 1:247574179:T:C | Y69H | 0.900 |
| 1:247574180:A:C | Y69S | 0.894 |
| 1:247574297:C:T | T108I | 0.894 |
| 1:247574244:G:C | E90D | 0.883 |
| 1:247574244:G:T | E90D | 0.883 |
| 1:247574246:A:T | N91I | 0.883 |
| 1:247574306:C:A | A111D | 0.883 |
| 1:247574189:T:G | I72S | 0.880 |
| 1:247549196:G:T | G2V | 0.873 |
| 1:247574243:A:C | E90A | 0.856 |
| 1:247574312:T:C | L113P | 0.854 |
| 1:247574246:A:C | N91T | 0.851 |
| 1:247574189:T:A | I72N | 0.845 |
dbSNP variants (sampled 300 via entrez): RS1000005905 (1:247531025 G>C,T), RS1000103261 (1:247566238 TTTTA>T,TTTTATTTA), RS1000125380 (1:247521393 C>T), RS1000196447 (1:247554026 C>T), RS1000236980 (1:247524698 T>G), RS1000317203 (1:247510095 A>G), RS1000375794 (1:247561063 C>T), RS1000392243 (1:247560718 T>A,C), RS1000426751 (1:247556723 G>A,C), RS1000486732 (1:247513286 TC>T), RS1000509842 (1:247519696 T>C), RS1000591061 (1:247508815 G>A), RS1000602193 (1:247568461 G>A,T), RS1000610833 (1:247526153 T>G), RS1000622063 (1:247509061 G>C,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
25 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004599_265 | Mean platelet volume | 3.000000e-54 |
| GCST004599_266 | Mean platelet volume | 1.000000e-60 |
| GCST004603_202 | Platelet count | 2.000000e-54 |
| GCST004603_203 | Platelet count | 3.000000e-86 |
| GCST004607_210 | Plateletcrit | 9.000000e-23 |
| GCST004607_211 | Plateletcrit | 4.000000e-43 |
| GCST004616_123 | Platelet distribution width | 1.000000e-47 |
| GCST004616_124 | Platelet distribution width | 5.000000e-75 |
| GCST004619_63 | Reticulocyte fraction of red cells | 8.000000e-15 |
| GCST004622_143 | Reticulocyte count | 1.000000e-17 |
| GCST006101_11 | Cardiometabolic and hematological traits | 3.000000e-34 |
| GCST010122_2 | Ceramide levels (C22:0) | 6.000000e-06 |
| GCST90002385_111 | High light scatter reticulocyte count | 2.000000e-11 |
| GCST90002392_260 | Mean corpuscular volume | 5.000000e-11 |
| GCST90002395_513 | Mean platelet volume | 4.000000e-59 |
| GCST90002395_514 | Mean platelet volume | 2.000000e-131 |
| GCST90002397_758 | Mean spheric corpuscular volume | 4.000000e-17 |
| GCST90002400_549 | Plateletcrit | 1.000000e-13 |
| GCST90002400_550 | Plateletcrit | 1.000000e-61 |
| GCST90002401_411 | Platelet distribution width | 1.000000e-50 |
| GCST90002401_412 | Platelet distribution width | 7.000000e-134 |
| GCST90002402_270 | Platelet count | 8.000000e-42 |
| GCST90002402_271 | Platelet count | 1.000000e-151 |
| GCST90002405_103 | Reticulocyte count | 1.000000e-20 |
| GCST90002406_125 | Reticulocyte fraction of red cells | 7.000000e-18 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004309 | platelet count |
| EFO:0007985 | platelet crit |
| EFO:0007984 | platelet component distribution width |
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects methylation, affects cotreatment, increases methylation | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| bisphenol S | affects cotreatment, increases methylation, decreases methylation | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Hydralazine | increases expression, affects cotreatment | 1 |
| Methotrexate | increases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Valproic Acid | increases expression, affects cotreatment | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.